Skip to main content
Livermore
Livermore
ZHEN

Equitable Holdings, Inc.

SEC CIK
0001333986
Latest filing
Aug 17, 2026

SLS holding history

SELLAS Life Sciences Group, Inc. in every 13F filed by Equitable Holdings, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SLS overviewAll 13F holders of SLSFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of SLS by Equitable Holdings, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−32,060−100.0%Sold outHolders
Q4 202532,060$120.9K<0.1%+5,000+18.5%AddedHolders
Q3 202527,060$43.6K<0.1%+10,000+58.6%AddedHolders
Q2 202517,060$37.4K<0.1%+5,000+41.5%AddedHolders
Q1 202512,060$13.0K<0.1%00.0%UnchangedHolders
Q4 202412,060$12.5K<0.1%00.0%UnchangedHolders
Q3 202412,060$15.1K<0.1%−197,940−94.3%ReducedHolders
Q2 2024210,000$249.9K<0.1%+10,000+5.0%AddedHolders
Q1 2024200,000$202.0K<0.1%+35,000+21.2%AddedHolders
Q4 2023165,000$174.9K<0.1%+30,000+22.2%AddedHolders
Q3 2023135,000$221.4K<0.1%00.0%UnchangedHolders
Q2 2023135,000$211.9K<0.1%+5,000+3.8%AddedHolders
Q1 2023130,000$185.9K<0.1%+17,000+15.0%AddedHolders
Q4 2022113,000$266.7K<0.1%+3,000+2.7%AddedHolders
Q3 2022110,000$222.0K<0.1%00.0%UnchangedHolders
Q2 2022110,000$245.0K<0.1%+6,000+5.8%AddedHolders
Q1 2022104,000$695.0K<0.1%+2,000+2.0%AddedHolders
Q4 2021102,000$564.0K<0.1%+2,000+2.0%AddedHolders
Q3 2021100,000$916.0K<0.1%+5,700+6.0%AddedHolders
Q2 202194,300$1.05M<0.1%00.0%UnchangedHolders
Q1 202194,300$805.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.